Yipin Yang
Overview
Explore the profile of Yipin Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang Y, Wang Y, Fan X, Xu X, Wang H, Wang X, et al.
Int J Mol Med
. 2024 Nov;
55(2).
PMID: 39575487
DNA methylation is one of the earliest discovered and most extensively studied epigenetic regulatory mechanisms. Broadly, DNA methylation refers to the transfer of a methyl group on S‑adenosine‑L‑methionine (SAM) to...
2.
Yang Y, Wang Y, Chen B, Liu Y, Gu K
Expert Opin Drug Saf
. 2024 Aug;
:1-13.
PMID: 39145923
Background: There is a need to determine lenvatinib-associated real-world adverse events (AEs) as its adverse effects may result in its discontinuation. Research Design And Methods: Lenvatinib-associated AEs were analyzed and...
3.
Chen B, Yang Y, Wang X, Yang W, Lu Y, Wang D, et al.
Int J Oncol
. 2024 Jul;
65(2).
PMID: 38994758
Cancer is characterized by unlimited proliferation and metastasis, and traditional therapeutic strategies usually result in the acquisition of drug resistance, thus highlighting the need for more personalized treatment. mRNA vaccines...
4.
Yang W, Yang Y, Wang Y, Gao Z, Zhang J, Gao W, et al.
Int J Mol Med
. 2024 Jul;
54(2).
PMID: 38963023
Metformin has been the go‑to medical treatment for addressing type 2 diabetes mellitus (T2DM) as a frontline oral antidiabetic. Obesity, cancer and bone deterioration are linked to T2DM, which is...
5.
Ma Q, Yang Y, Chen S, Cheng H, Gong P, Hao J
Mol Biol Rep
. 2024 Jan;
51(1):229.
PMID: 38281249
Background: Cancer is still a leading cause of mortality. Over the years, cancer therapy has undergone significant advances driven by advancements in science and technology. A promising area of drug...
6.
Liu Y, Yang Y, Wang X, Yin S, Liang B, Zhang Y, et al.
Int J Oncol
. 2023 Dec;
64(1).
PMID: 38038165
Non‑coding RNAs with a length of 22‑24 nt are known as microRNAs (miRNAs or miRs), which are critical regulators of protein translation. Over the past 10 years, the roles of...
7.
Ge S, Zhu X, Xu Q, Wang J, An C, Hu Y, et al.
Front Pharmacol
. 2022 Oct;
13:957660.
PMID: 36210838
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of systemic autoimmune diseases, which is typified by inflammatory necrosis predominantly affecting the small vessels and often accompanied by positive ANCA....